Revolution Medicines Wins FDA Approval for First-of-Its-Kind Pancreatic Cancer Drug

26 Aug 2026 · 18:34 UTC

Observed price moves

RVMD-0.30%1 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.